Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
ON-EYE POSITIONING OF CORNEAL REFRACTIVE THERAPY TREATMENT ZONES
Author Affiliations & Notes
  • Grace Walther
    Optometry, Indiana University, Bloomington, Indiana, United States
  • Liandra Jung
    Optometry, University of California Berkeley, Berkeley, California, United States
  • Francisco Javier Gantes-Nuñez
    Optometry, Indiana University, Bloomington, Indiana, United States
  • Maria Liu
    Optometry, University of California Berkeley, Berkeley, California, United States
  • Pete S Kollbaum
    Optometry, Indiana University, Bloomington, Indiana, United States
  • Footnotes
    Commercial Relationships   Grace Walther None; Liandra Jung None; Francisco Gantes-Nuñez None; Maria Liu CooperVision, Code F (Financial Support); Pete Kollbaum CooperVision, Code F (Financial Support)
  • Footnotes
    Support  Research support provided by CooperVision
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2700. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Grace Walther, Liandra Jung, Francisco Javier Gantes-Nuñez, Maria Liu, Pete S Kollbaum; ON-EYE POSITIONING OF CORNEAL REFRACTIVE THERAPY TREATMENT ZONES. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2700.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recent evidence shows that in addition to providing a refractive correction for myopia, orthokeratology/Corneal Refractive Therapy (CRT) also acts to slow myopia progression. Understanding where CRT lenses are positioned on-eye, relative to the primary line of sight (pupil center) may help understand treatment effectiveness. It is not possible to measure lens position during overnight wear due to lid closure, however refractive change maps can identify the corneal treatment zone location created by lens position during overnight treatment. The current project evaluates CRT lens decentration on first-time wearers following 1 day, 1, 2 and 4 weeks of nightly treatment.

Methods : Aberrometry data from both eyes of 10 participants was collected following lens removal along the primary line of sight with monocular, distance fixation in a dark room (< 3 cd/m2). All eyes were randomized to wear Paragon CRT lenses (paflufocon B, CooperVision) of either 5- or 6-mm optical zone diameters, one lens design in each eye. Manufacturer’s fitting guide was followed to determine lens parameters. Custom software was used to calculate refractive state maps from which treatment zone centration was measured.

Results : Participants (7 Asian) were 22-30 years old, (average±stdev 24.5±2.1years) with spherical equivalent of -2.44±1.54D. Following 1 night of wear, corneal treatment zones centered well inferiorly (-0.14±0.21mm) and temporally (-0.07±0.20mm). Following 1 week of nightly lens wear, CRT lenses remained in similar positions as seen at 1 day, inferiorly (-0.10±0.17mm) and temporally (-0.18±0.15mm). Lens positions similar to 1 day were also seen following 2 and 4 weeks of nightly lens wear (2 weeks: -0.12±0.16mm inferior and -0.21±0.15mm temporal; 4 weeks: -0.11±0.13mm inferior and -0.19±0.16mm temporal). No significant difference was found in treatment zone centration between lenses with 5 or 6mm back optic zone diameter.

Conclusions : During initial lens fitting clinicians aim to fit CRT lenses so they center well relative to the cornea. Refractive state maps derived from aberrometry data confirm that the CRT treatment zones also generally centered well on the pupil following 1 night of closed-eye lens wear, and treatment patterns remain stable over 4 weeks of nightly lens wear. These results confirm that clinical procedures to achieve lens-cornea centration with open eyelids, achieve central corneal flattening relative to the pupil center.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×